Skip to content

Andrew J. Schwab, Director at Camp4 Therapeutics, sold CAMP on Aug 21, 2026

Data as of Oct 16

▼ SELL$144K32,018 shares at $4.50Andrew J. Schwab DirectorCAMP Camp4 Therapeutics Corp
Watch CAMP
Traded
Aug 21, 2026
Disclosed
Aug 21, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Andrew J. Schwab, Director at Camp4 Therapeutics, sold CAMP on Aug 21, 2026TRADEDDISCLOSED
CAMPSimilar stocks (XLV — its sector index fund), rebased to CAMP's price on the disclosure day
CAMP since disclosure
−29.2%
after the sale
Similar stocks (XLV) since disclosure
+1.2%
XLV — its sector index fund

Change in closing price from Aug 21, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAndrew J. Schwab DirectorCAMP Camp4 Therapeutics Corp$521Kdisclosed Aug 21 · filed 1 day after the trade
  2. ▼ SELLAndrew J. Schwab DirectorCAMP Camp4 Therapeutics Corp$215Kdisclosed Aug 21 · filed 2 days after the trade

See every trade on CAMP →